The Francis Crick Institute

sorry, we can't preview this file

32868333.pdf (242.73 kB)

Natural polymorphisms in Mycobacterium tuberculosis conferring resistance to delamanid in drug-naive patients.

Download (242.73 kB)
journal contribution
posted on 2020-10-23, 13:11 authored by Martina L Reichmuth, Rico Hömke, Kathrin Zürcher, Peter Sander, Anchalee Avihingsanon, Jimena Collantes, Chloé Loiseau, Sonia Borrell, Miriam Reinhard, Robert J Wilkinson, Marcel Yotebieng, Lukas Fenner, Erik C Böttger, Sebastien Gagneux, Matthias Egger, Peter M Keller, International epidemiology Databases to Evaluate AIDS (IeDEA)
Mutations in the genes of the F420 signaling pathway, including dnn, fgd1, fbiA, fbiB, fbiC, and fbiD, of Mycobacterium tuberculosis (Mtb) complex can lead to delamanid resistance. We searched for such mutations among 129 Mtb strains from Asia, South-America, and Africa using whole-genome sequencing; 70 (54%) strains had at least one mutation in one of the genes. For ten strains with mutations, we determined the minimum inhibitory concentration (MIC) of delamanid. We found one strain from a delamanid-naïve patient carrying the natural polymorphism Tyr29del (ddn) that was associated with a critical MIC to delamanid.


Crick (Grant ID: 10218, Grant title: Wilkinson, R FC001218)